1 week Ago By Defense World Staff
Wells Fargo & Company MN lessened its holdings in Teleflex Incorporated (NYSE:TFX – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,105 shares of the medical technology company’s stock after selling 2,117 shares during the quarter.
Wells Fargo & Company MN’s holdings in Teleflex were worth $2,332,000 as of its most recent SEC filing. Several other hedge funds also recently made changes to their positions in the business. Hengehold Capital Management LLC boosted its holdings in shares of Teleflex by 7.
3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock valued at $229,000 after purchasing an additional 88 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in shares of Teleflex by 38.
2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after buying an additional 94 shares during the period. Isthmus Partners LLC increased its stake in Teleflex by 7.
3% during the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after purchasing an additional 105 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in Teleflex by 2.
4% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock valued at $888,000 after purchasing an additional 118 shares during the last quarter. Finally, QRG Capital Management Inc.
lifted its stake in Teleflex by 5.8% during the 4th quarter. QRG Capital Management Inc.
now owns 2,178 shares of the medical technology company’s stock valued at $388,000 after acquiring an additional 119 shares in the last quarter. 95.62% of the stock is owned by institutional investors.
Teleflex Stock Down 0.4 %TFX stock opened at $135.08 on Friday.
The company has a market capitalization of $6.26 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 1.
73 and a beta of 1.19. The business’s 50 day moving average price is $140.
16 and its two-hundred day moving average price is $174.33. Teleflex Incorporated has a fifty-two week low of $124.
66 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.
37, a quick ratio of 1.39 and a current ratio of 2.42.
Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts’ consensus estimates of $3.
86 by $0.03. The firm had revenue of $795.
40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.
19% and a net margin of 7.85%. As a group, analysts forecast that Teleflex Incorporated will post 13.
98 earnings per share for the current fiscal year. Teleflex Announces DividendThe firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.
34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.
01%. The ex-dividend date was Friday, March 7th. Teleflex’s payout ratio is 95.
77%. Analyst Ratings ChangesTFX has been the subject of several research reports. Mizuho set a $155.
00 price target on shares of Teleflex in a research report on Wednesday, April 16th. Wells Fargo & Company lowered their target price on shares of Teleflex from $214.00 to $146.
00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $235.00 to $140.
00 in a research report on Tuesday, March 4th. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th.
One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Teleflex currently has an average rating of “Hold” and an average price target of $169.
63.Get Our Latest Research Report on TFXTeleflex Profile (Free Report)Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Read MoreFive stocks we like better than TeleflexWhat Are Dividend Contenders? Investing in Dividend ContendersShort Sellers Gave Up on These 3 Names RecentlyStock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed3 Boring Stocks Outperforming the Market This YearInvesting in Construction StocksIf You Wanted To Buy AbbVie and Didn’t, There’s Still Time To BuyWant to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report)..
